Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

Leukotrienes and the lung.

A G Leitch

    Clinical Science (London, England : 1979)
    |August 1, 1984
    PubMed
    Summary
    This summary is machine-generated.

    Leukotrienes are potent substances involved in obstructive airways disease. Further research and safe human antagonists are needed to determine their exact role and develop effective treatments for lung diseases.

    Related Concept Videos

    You might also read

    Related Articles

    Articles linked to this work by shared authors, journal, and citation graph.

    Sort by
    Same author

    The management of pulmonary tuberculosis in adults notified in Scotland in 1993.

    Respiratory medicine·1999
    Same author

    Procedures for developing a simple scoring method based on unsophisticated criteria for screening children for tuberculosis.

    The international journal of tuberculosis and lung disease : the official journal of the International Union against Tuberculosis and Lung Disease·1998
    Same author

    Surveillance of tuberculosis in Europe. Working Group of the World Health Organization (WHO) and the European Region of the International Union Against Tuberculosis and Lung Disease (IUATLD) for uniform reporting on tuberculosis cases.

    The European respiratory journal·1996
    Same author

    Two men and a bug: one hundred years of tuberculosis in Edinburgh.

    Proceedings of the Royal College of Physicians of Edinburgh·1996
    Same author

    Increasing incidence of tuberculosis in the young and the elderly in Scotland.

    Thorax·1996
    Same author

    Scottish national survey of tuberculosis notifications 1993 with special reference to the prevalence of HIV seropositivity.

    Thorax·1996
    Same journal

    HDAC9 promotes atherosclerosis by suppressing CYP7A1 and impairing hepatic cholesterol excretion.

    Clinical science (London, England : 1979)·2026
    Same journal

    Clusterin ameliorates LPS-induced ARDS by inhibiting the Wnt/β-catenin pathway.

    Clinical science (London, England : 1979)·2026
    Same journal

    Human cytomegalovirus at the maternal-fetal interface: an overview of pathogenesis, defence, and interventions.

    Clinical science (London, England : 1979)·2026
    Same journal

    Cardiometabolic regulation by adipocyte-derived leptin and the brain melanocortin system.

    Clinical science (London, England : 1979)·2026
    Same journal

    Impact of impaired branched-chain amino acid metabolism on kidney disease.

    Clinical science (London, England : 1979)·2026
    Same journal

    Ex vivo pretreatment of donor organ with siRNA nanoparticles attenuates cold ischemia-reperfusion injury in cardiac transplantation.

    Clinical science (London, England : 1979)·2026
    See all related articles

    Area of Science:

    • Biochemistry
    • Pharmacology
    • Pulmonary Medicine

    Background:

    • Leukotrienes are potent inflammatory mediators.
    • These substances are implicated in obstructive airways diseases.

    Purpose of the Study:

    • To review the history, biosynthesis, and biological activities of leukotrienes.
    • To discuss the potential role of leukotrienes in lung diseases.

    Main Methods:

    • Literature review of leukotriene research.
    • Discussion of in vitro and potential in vivo studies.

    Main Results:

    • Leukotrienes are potent substances.
    • They likely play a significant role in reversible obstructive airways disease.
    • Their precise contribution to lung diseases requires further investigation.

    Related Experiment Videos

    Conclusions:

    • Leukotrienes are key players in obstructive airways disease.
    • Development of safe leukotriene antagonists or 5-lipoxygenase inhibitors is crucial for therapeutic advancement.
    • Combination therapy with antihistamines and leukotriene antagonists may offer a future treatment strategy for airway smooth muscle constriction.